Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2015
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Elena Bandieri, Marilena Romero, Carla Ida Ripamonti, et al.
JCO Oncology Practice
|
December 20, 2019
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy
Valentina Guarneri, Paolo Pronzato, Oscar Bertetto, et al.
Genes
|
July 2, 2021
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy
Sara Baglivo, Fortunato Bianconi, Giulio Metro, et al.
Frontiers in Immunology
|
June 16, 2020
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
Martina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Scientific Reports
|
November 17, 2023
Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience
Carmen Molica, Alessio Gili, Carlotta Nardelli, et al.
Genes
|
March 6, 2021
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients
Vienna Ludovini, Fortunato Bianconi, Annamaria Siggillino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2003
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group
Paul J Hesketh, Steven M Grunberg, Richard J Gralla, et al.
Therapeutic Advances in Medical Oncology
|
August 1, 2020
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
Francesco Gelsomino, Giuseppe Lamberti, Marcello Tiseo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 8, 2018
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
Fausto Roila, Guglielmo Fumi, Benedetta Ruggeri, et al.
The Oncologist
|
March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders
Andrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2015
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Elena Bandieri, Marilena Romero, Carla Ida Ripamonti, et al.
JCO Oncology Practice
|
December 20, 2019
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy
Valentina Guarneri, Paolo Pronzato, Oscar Bertetto, et al.
Genes
|
July 2, 2021
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy
Sara Baglivo, Fortunato Bianconi, Giulio Metro, et al.
Frontiers in Immunology
|
June 16, 2020
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
Martina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Scientific Reports
|
November 17, 2023
Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience
Carmen Molica, Alessio Gili, Carlotta Nardelli, et al.
Genes
|
March 6, 2021
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients
Vienna Ludovini, Fortunato Bianconi, Annamaria Siggillino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2003
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group
Paul J Hesketh, Steven M Grunberg, Richard J Gralla, et al.
Therapeutic Advances in Medical Oncology
|
August 1, 2020
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
Francesco Gelsomino, Giuseppe Lamberti, Marcello Tiseo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 8, 2018
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
Fausto Roila, Guglielmo Fumi, Benedetta Ruggeri, et al.
The Oncologist
|
March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders
Andrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
Page
of 10